AcquisitionVectivBio expands rare disease pipelineLatest NewsSwiss rare disease specialist VectivBio Holding AG is taking over US biotech Comet Therapeutics Inc. for an undisclosed amount. Comet focusses on treatments for metabolic diseases. Read more 31 August 2021 https://european-biotechnology.com/wp-content/uploads/2024/04/dna-6517209_1920.jpg 1275 1920 Uta Mommert /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Uta Mommert2021-08-31 17:17:002024-04-15 15:23:46VectivBio expands rare disease pipeline